Literature DB >> 20930746

A small kiss of death for cancer.

Angelika Eggert, Johannes H Schulte.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20930746     DOI： 10.1038/nm1010-1079

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  13 in total

Review 1.  MicroRNAs: genomics, biogenesis, mechanism, and function.

Authors:  David P Bartel
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

2.  miR-380-5p represses p53 to control cellular survival and is associated with poor outcome in MYCN-amplified neuroblastoma.

Authors:  Alexander Swarbrick; Susan L Woods; Alexander Shaw; Asha Balakrishnan; Yuwei Phua; Akira Nguyen; Yvan Chanthery; Lionel Lim; Lesley J Ashton; Robert L Judson; Noelle Huskey; Robert Blelloch; Michelle Haber; Murray D Norris; Peter Lengyel; Christopher S Hackett; Thomas Preiss; Albert Chetcuti; Christopher S Sullivan; Eric G Marcusson; William Weiss; Noelle L'Etoile; Andrei Goga
Journal:  Nat Med       Date:  2010-09-26       Impact factor: 53.440

3.  Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas.

Authors:  Wen Xue; Lars Zender; Cornelius Miething; Ross A Dickins; Eva Hernando; Valery Krizhanovsky; Carlos Cordon-Cardo; Scott W Lowe
Journal:  Nature       Date:  2007-01-24       Impact factor: 49.962

Review 4.  microRNAs join the p53 network--another piece in the tumour-suppression puzzle.

Authors:  Lin He; Xingyue He; Scott W Lowe; Gregory J Hannon
Journal:  Nat Rev Cancer       Date:  2007-11       Impact factor: 60.716

5.  Accurate prediction of neuroblastoma outcome based on miRNA expression profiles.

Authors:  Johannes H Schulte; Benjamin Schowe; Pieter Mestdagh; Lars Kaderali; Prabhav Kalaghatgi; Stefanie Schlierf; Joelle Vermeulen; Bent Brockmeyer; Kristian Pajtler; Theresa Thor; Katleen de Preter; Frank Speleman; Katharina Morik; Angelika Eggert; Jo Vandesompele; Alexander Schramm
Journal:  Int J Cancer       Date:  2010-11-15       Impact factor: 7.396

Review 6.  Recent advances in neuroblastoma.

Authors:  John M Maris
Journal:  N Engl J Med       Date:  2010-06-10       Impact factor: 91.245

7.  MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells.

Authors:  C Welch; Y Chen; R L Stallings
Journal:  Oncogene       Date:  2007-02-12       Impact factor: 9.867

Review 8.  The expanding universe of p53 targets.

Authors:  Daniel Menendez; Alberto Inga; Michael A Resnick
Journal:  Nat Rev Cancer       Date:  2009-10       Impact factor: 60.716

Review 9.  Regulating the genome surveillance system: miRNAs and the p53 super family.

Authors:  Sarah G Bailey; Tilman Sanchez-Elsner; Anastasis Stephanou; Mark S Cragg; Paul A Townsend
Journal:  Apoptosis       Date:  2010-05       Impact factor: 4.677

Review 10.  The miR-34 family in cancer and apoptosis.

Authors:  H Hermeking
Journal:  Cell Death Differ       Date:  2009-05-22       Impact factor: 15.828
View more
  4 in total

Review 1.  MicroRNA and DNA methylation alterations mediating retinoic acid induced neuroblastoma cell differentiation.

Authors:  Raymond L Stallings; Niamh H Foley; Isabella M Bray; Sudipto Das; Patrick G Buckley
Journal:  Semin Cancer Biol       Date:  2011-07-13       Impact factor: 15.707

Review 2.  MicroRNA expression and its association with DNA repair in preimplantation embryos.

Authors:  Pinar Tulay; Sioban B Sengupta
Journal:  J Reprod Dev       Date:  2016-02-05       Impact factor: 2.214

Review 3.  MiRNA Influences in Neuroblast Modulation: An Introspective Analysis.

Authors:  Vanessa Zammit; Byron Baron; Duncan Ayers
Journal:  Genes (Basel)       Date:  2018-01-09       Impact factor: 4.096

4.  MicroRNAs define distinct human neuroblastoma cell phenotypes and regulate their differentiation and tumorigenicity.

Authors:  Leleesha Samaraweera; Kathryn B Grandinetti; Ruojun Huang; Barbara A Spengler; Robert A Ross
Journal:  BMC Cancer       Date:  2014-05-02       Impact factor: 4.430
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.